class name | count |
---|
class name | count |
---|---|
Halichondriidae | 2 |
Prorocentraceae | 2 |
br08003 Category | # of metabolite |
---|
br08003 Category | KEGG ID | KNApSAcK ID |
---|
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
figure |
---|---|---|---|---|---|---|
C00039897
![]() |
Okadaic acid
|
CHEMBL280487
CHEMBL158524 CHEMBL1269053 CHEMBL1454935 CHEMBL1613688 CHEMBL1728497 CHEMBL2006105 CHEMBL2068811 CHEMBL2304065 |
D019319
|
18 / 28 / 46 | 77 / 5 |
![]() |
C00045871
![]() |
DTX-6
/ (+)-DTX-6 |
![]() |
||||
C00048629
![]() |
Belizeanic acid
/ (+)-Belizeanic acid |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00039897 | 0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00039897 | 7 / 37 |
Q99700 | Ataxin-2 | Unclassified protein | C00039897 | 1 / 1 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00039897 | 2 / 0 |
Q15172 | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform | Protein phosphatase regulatory subunit | C00039897 | 0 / 0 |
P37840 | Alpha-synuclein | Unclassified protein | C00039897 | 4 / 2 |
O75688 | Protein phosphatase 1B | Ser_Thr | C00039897 | 0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00039897 | 2 / 0 |
O75496 | Geminin | Unclassified protein | C00039897 | 0 / 0 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00039897 | 7 / 3 |
P36873 | Serine/threonine-protein phosphatase PP1-gamma catalytic subunit | Ser_Thr | C00039897 | 0 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00039897 | 0 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00039897 | 0 / 1 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00039897 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00039897 | 4 / 3 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00039897 | 0 / 0 |
P67775 | Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform | Ser_Thr | C00039897 | 0 / 0 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00039897 | 1 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00039897
|
226 | ALDOA, ALDA, GSD12 | aldolase A, fructose-bisphosphate (EC:4.1.2.13) |
C00039897
|
498 | ATP5A1, ATP5A, ATP5AL2, ATPM, MC5DN4, MOM2, OMR, ORM, hATP1 | ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle |
C00039897
|
513 | ATP5D | ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit (EC:3.6.1.14) |
C00039897
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00039897
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00039897
|
27101 | CACYBP, GIG5, RP1-102G20.6, S100A6BP, SIP | calcyclin binding protein |
C00039897
|
843 | CASP10, ALPS2, FLICE2, MCH4 | caspase 10, apoptosis-related cysteine peptidase (EC:3.4.22.63) |
C00039897
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00039897
|
840 | CASP7, CASP-7, CMH-1, ICE-LAP3, LICE2, MCH3 | caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) |
C00039897
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00039897
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00039897
|
8900 | CCNA1 | cyclin A1 |
C00039897
|
9133 | CCNB2, HsT17299 | cyclin B2 |
C00039897
|
983 | CDK1, CDC2, CDC28A, P34CDC2 | cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) |
C00039897
|
1017 | CDK2, p33(CDK2) | cyclin-dependent kinase 2 (EC:2.7.11.22) |
C00039897
|
1072 | CFL1, CFL | cofilin 1 (non-muscle) |
C00039897
|
1080 | CFTR, ABC35, ABCC7, CF, CFTR/MRP, MRP7, TNR-CFTR, dJ760C5.1 | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49) |
C00039897
|
54927 | CHCHD3, MINOS3, PPP1R22 | coiled-coil-helix-coiled-coil-helix domain containing 3 |
C00039897
|
1139 | CHRNA7, CHRNA7-2, NACHRA7 | cholinergic receptor, nicotinic, alpha 7 (neuronal) |
C00039897
|
1141 | CHRNB2, EFNL3, nAChRB2 | cholinergic receptor, nicotinic, beta 2 (neuronal) |
C00039897
|
1207 | CLNS1A, CLCI, CLNS1B, ICln | chloride channel, nucleotide-sensitive, 1A |
C00039897
|
1312 | COMT | catechol-O-methyltransferase (EC:2.1.1.6) |
C00039897
|
1387 | CREBBP, CBP, KAT3A, RSTS | CREB binding protein (EC:2.3.1.48) |
C00039897
|
1499 | CTNNB1, CTNNB, MRD19, armadillo | catenin (cadherin-associated protein), beta 1, 88kDa |
C00039897
|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00039897
|
1601 | DAB2, DOC-2, DOC2 | Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila) |
C00039897
|
10521 | DDX17, P72, RH70 | DEAD (Asp-Glu-Ala-Asp) box helicase 17 (EC:3.6.4.13) |
C00039897
|
11034 | DSTN, ACTDP, ADF, bA462D18.2 | destrin (actin depolymerizing factor) |
C00039897
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00039897
|
2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00039897
|
2739 | GLO1, GLOD1, GLYI | glyoxalase I (EC:4.4.1.5) |
C00039897
|
2932 | GSK3B | glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) |
C00039897
|
3315 | HSPB1, CMT2F, HMN2B, HS.76067, HSP27, HSP28, Hsp25, SRP27 | heat shock 27kDa protein 1 |
C00039897
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00039897
|
3717 | JAK2, JTK10, THCYT3 | Janus kinase 2 (EC:2.7.10.2) |
C00039897
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00039897
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00039897
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00039897
|
5598 | MAPK7, BMK1, ERK4, ERK5, PRKM7 | mitogen-activated protein kinase 7 (EC:2.7.11.24) |
C00039897
|
4137 | MAPT, DDPAC, FTDP-17, MAPTL, MSTD, MTBT1, MTBT2, PPND, TAU | microtubule-associated protein tau |
C00039897
|
5469 | MED1, CRSP1, CRSP200, DRIP205, DRIP230, PBP, PPARBP, PPARGBP, RB18A, TRAP220, TRIP2 | mediator complex subunit 1 |
C00039897
|
23184 | MESDC2, BOCA, MESD | mesoderm development candidate 2 |
C00039897
|
4625 | MYH7, CMD1S, CMH1, MPD1, MYHCB, SPMD, SPMM | myosin, heavy chain 7, cardiac muscle, beta |
C00039897
|
54187 | NANS, SAS | N-acetylneuraminic acid synthase (EC:2.5.1.56 2.5.1.57) |
C00039897
|
9611 | NCOR1, N-CoR, N-CoR1, TRAC1, hN-CoR | nuclear receptor corepressor 1 |
C00039897
|
4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00039897
|
4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00039897
|
4830 | NME1, AWD, GAAD, NB, NBS, NDKA, NDPK-A, NDPKA, NM23, NM23-H1 | NME/NM23 nucleoside diphosphate kinase 1 (EC:2.7.4.6) |
C00039897
|
8856 | NR1I2, BXR, ONR1, PAR, PAR1, PAR2, PARq, PRR, PXR, SAR, SXR | nuclear receptor subfamily 1, group I, member 2 |
C00039897
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00039897
|
5093 | PCBP1, HNRPE1, HNRPX, hnRNP-E1, hnRNP-X | poly(rC) binding protein 1 |
C00039897
|
5110 | PCMT1, PIMT | protein-L-isoaspartate (D-aspartate) O-methyltransferase (EC:2.1.1.77) |
C00039897
|
3651 | PDX1, GSF, IDX-1, IPF1, IUF1, MODY4, PDX-1, STF-1 | pancreatic and duodenal homeobox 1 |
C00039897
|
5223 | PGAM1, PGAM-B, PGAMA | phosphoglycerate mutase 1 (brain) (EC:3.1.3.13 5.4.2.4 5.4.2.11) |
C00039897
|
5241 | PGR, NR3C3, PR | progesterone receptor |
C00039897
|
5465 | PPARA, NR1C1, PPAR, PPARalpha, hPPAR | peroxisome proliferator-activated receptor alpha |
C00039897
|
5478 | PPIA, CYPA, CYPH | peptidylprolyl isomerase A (cyclophilin A) (EC:5.2.1.8) |
C00039897
|
5499 | PPP1CA, PP-1A, PP1A, PP1alpha, PPP1A | protein phosphatase 1, catalytic subunit, alpha isozyme (EC:3.1.3.16) |
C00039897
|
5515 | PPP2CA, PP2Ac, PP2CA, PP2Calpha, RP-C | protein phosphatase 2, catalytic subunit, alpha isozyme (EC:3.1.3.16) |
C00039897
|
5518 | PPP2R1A, PP2A-Aalpha, PP2AAALPHA, PR65A | protein phosphatase 2, regulatory subunit A, alpha (EC:3.1.3.16) |
C00039897
|
25824 | PRDX5, ACR1, AOEB166, B166, PLP, PMP20, PRDX6, PRXV, prx-V | peroxiredoxin 5 (EC:1.11.1.15) |
C00039897
|
9588 | PRDX6, 1-Cys, AOP2, NSGPx, PRX, aiPLA2, p29 | peroxiredoxin 6 (EC:1.11.1.9 1.11.1.15) |
C00039897
|
5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00039897
|
5933 | RBL1, CP107, PRB1, p107 | retinoblastoma-like 1 (p107) |
C00039897
|
5934 | RBL2, P130, Rb2 | retinoblastoma-like 2 (p130) |
C00039897
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00039897
|
6206 | RPS12, S12 | ribosomal protein S12 |
C00039897
|
6256 | RXRA, NR2B1 | retinoid X receptor, alpha |
C00039897
|
6406 | SEMG1, CT103, SEMG, SGI, dJ172H20.2 | semenogelin I |
C00039897
|
6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) |
C00039897
|
6648 | SOD2, IPOB, MNSOD, MVCD6 | superoxide dismutase 2, mitochondrial (EC:1.15.1.1) |
C00039897
|
7018 | TF, PRO1557, PRO2086, TFQTL1 | transferrin |
C00039897
|
8743 | TNFSF10, APO2L, Apo-2L, CD253, TL2, TRAIL | tumor necrosis factor (ligand) superfamily, member 10 |
C00039897
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00039897
|
7295 | TXN, TRDX, TRX, TRX1 | thioredoxin |
C00039897
|
7421 | VDR, NR1I1 | vitamin D (1,25- dihydroxyvitamin D3) receptor |
C00039897
|
OMIM | preferred title | UniProt |
---|---|---|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#114500 | Colorectal cancer; crc |
P84022
|
#127750 | Dementia, lewy body; dlb |
P37840
|
#133239 | Esophageal cancer |
P04637
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#211980 | Lung cancer |
P04637
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#168601 | Parkinson disease 1, autosomal dominant; park1 |
P37840
|
#605543 | Parkinson disease 4, autosomal dominant; park4 |
P37840
|
#168600 | Parkinson disease, late-onset; pd |
P37840
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#172700 | Pick disease of brain |
P10636
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
KEGG | name | UniProt |
---|---|---|
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) |
H00018 | Gastric cancer |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00022 | Bladder cancer |
P04637
(related)
|
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) |
H00026 | Endometrial Cancer |
P04637
(related)
|
H00027 | Ovarian cancer |
P04637
(related)
|
H00028 | Choriocarcinoma |
P04637
(related)
|
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
|
H00033 | Adrenal carcinoma |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00042 | Glioma |
P04637
(related)
P04637 (marker) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00057 | Parkinson's disease (PD) |
P37840
(related)
|
H00066 | Lewy body dementia (LBD) |
P37840
(related)
|
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|